Фармакоэкономика (Feb 2024)

Peculiarities of real-world data application for health technology assessment in Asian countries

  • B. B. Kondratyeva,
  • F. V. Gorkavenko,
  • V. V. Omelyanovskiy

DOI
https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.199
Journal volume & issue
Vol. 16, no. 4
pp. 671 – 680

Abstract

Read online

The article is devoted to the study of regulatory approaches to the sphere of real-world data (RWD) and real world evidence (RWE) in the countries of the Asia-Pacific Region (China, South Korea, Japan, Taiwan, etc.) and examples of their practical application for health technology assessment. The peculiarities of collecting and gaining access to RWD/RWE in Asian countries, prerequisites for the development of this direction, adopted regulations, developed methodological guidelines, promising areas of application, and clinical and economic research based on country-specific data are considered. The existing practices in Asian countries represent valuable experience, some of which could be considered for implementation in the national practice.

Keywords